|
RADIATION THERAPY ONCOLOGY GROUP
|
3U10CA021661-32S2
|
$9,611,397
|
$768,912
|
CURRAN, WALTER
|
AMERICAN COLLEGE OF RADIOLOGY
|
|
RADIATION THERAPY ONCOLOGY GROUP
|
3U10CA021661-32S3
|
$3,952
|
$316
|
CURRAN, WALTER
|
AMERICAN COLLEGE OF RADIOLOGY
|
|
RADIATION THERAPY ONCOLOGY GROUP
|
3U10CA021661-32S4
|
$80,640
|
$6,451
|
CURRAN, WALTER
|
AMERICAN COLLEGE OF RADIOLOGY
|
|
Community Clinical Oncology Program Research Base
|
3U10CA037422-21S1
|
$27,801
|
$2,224
|
CURRAN, WALTER
|
AMERICAN COLLEGE OF RADIOLOGY
|
|
Community Clinical Oncology Program Research Base
|
5U10CA037422-21
|
$1,665,362
|
$133,229
|
CURRAN, WALTER
|
AMERICAN COLLEGE OF RADIOLOGY
|
|
Radiation Therapy Oncology Group-Statistical Center
|
3U10CA032115-26S1
|
$1,010,519
|
$80,842
|
Sadek, Ramses
|
AMERICAN COLLEGE OF RADIOLOGY
|
|
Drug Delivery Carriers Targeted to Breast Tumor by Fusion Phage Proteins
|
5R01CA125063-02
|
$373,539
|
$93,385
|
PETRENKO, VALERY
|
AUBURN UNIVERSITY AT AUBURN
|
|
Bay Area Tumor Institute CCOP
|
5U10CA045461-19
|
$481,201
|
$52,932
|
Feusner, James
|
BAY AREA TUMOR INSTITUTE
|
|
Targeting Notch, PI3K-AKT and other novel pathways in breast cancer stem cells
|
1R01CA138197-01
|
$475,325
|
$47,533
|
CHANG, JENNY
|
BAYLOR COLLEGE OF MEDICINE
|
|
Breast cancer response markers to a dual HER1/2 blocker
|
5R01CA112305-04
|
$252,236
|
$83,238
|
CHANG, JENNY
|
BAYLOR COLLEGE OF MEDICINE
|
|
NSABP Participating Sites
|
5U10CA118735-03
|
$66,231
|
$3,312
|
CHANG, JENNY
|
BAYLOR COLLEGE OF MEDICINE
|
|
Baylor College of Medicine Cancer Center
|
3P30CA125123-02S1
|
$117,286
|
$1,173
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
Baylor College of Medicine Cancer Center
|
5P30CA125123-02
|
$1,515,000
|
$15,150
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
Virginia Mason Community Clinical Oncology Program
|
5U10CA035192-25
|
$453,250
|
$58,923
|
Vuky, Jacqueline
|
BENAROYA RESEARCH INST AT VIRGINIA MASON
|
|
Eastern Cooperative Oncology Group
|
5U10CA080775-10
|
$128,678
|
$19,302
|
ATKINS, MICHAEL
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
Dana-Farber/Harvard Cancer Center Ovarian Cancer SPORE
|
5P50CA105009-05
|
$2,176,201
|
$435,240
|
CRAMER, DANIEL
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Functional Analysis of Histologic Grade in Breast Cancer
|
5R01CA109325-04
|
$261,573
|
$13,079
|
DAIRKEE, SHANAZ
|
CALIFORNIA PACIFIC MED CTR RES INSTITUTE
|
|
Carle Cancer Center Community Clinical Oncology Program
|
2U10CA035195-25
|
$855,703
|
$136,912
|
ROWLAND, KENDRITH
|
CARLE CLINIC ASSOCIATION, P C
|
|
Eastern Cooperative Oncology Group Studies
|
5U10CA014548-34
|
$417,899
|
$62,685
|
AVERBOOK, BRUCE
|
CASE WESTERN RESERVE UNIVERSITY
|
|
Early Clinical Trials of New Anti-Cancer Agents with Phase I Emphasis
|
2U01CA062502-15
|
$751,074
|
$7,511
|
DOWLATI, AFSHIN
|
CASE WESTERN RESERVE UNIVERSITY
|
|
Case Comprehensive Cancer Center Support Grant
|
3P30CA043703-18S3
|
$234,254
|
$4,685
|
GERSON, STANTON
|
CASE WESTERN RESERVE UNIVERSITY
|
|
Case Comprehensive Cancer Center Support Grant
|
3P30CA043703-19S1
|
$72,416
|
$1,448
|
GERSON, STANTON
|
CASE WESTERN RESERVE UNIVERSITY
|
|
Case Comprehensive Cancer Center Support Grant
|
3P30CA043703-19S2
|
|
$0
|
GERSON, STANTON
|
CASE WESTERN RESERVE UNIVERSITY
|
|
Case Comprehensive Cancer Center Support Grant
|
5P30CA043703-19
|
$5,104,000
|
$102,080
|
GERSON, STANTON
|
CASE WESTERN RESERVE UNIVERSITY
|
|
Molecular Targeting of Bcl-xL Pathway in Cancer
|
5R01CA109181-05
|
$265,033
|
$265,033
|
HALDAR, SUBRATA
|
CASE WESTERN RESERVE UNIVERSITY
|
|
Cedar Rapids Oncology Project
|
2U10CA052352-19
|
$575,627
|
$74,832
|
WIESENFELD, MARTIN
|
CEDAR RAPIDS ONCOLOGY PROJECT
|
|
Investigating the Role of Cyr61 in Breast Cancer
|
5R01CA109295-05
|
$297,342
|
$14,867
|
Koeffler, H.
|
CEDARS-SINAI MEDICAL CENTER
|
|
Array-assisted Insertional Mutagenesis Platform for Forward Genetics of Cancer
|
1R43CA132841-01
|
$92,940
|
$92,940
|
CHENCHIK, ALEX
|
CELLECTA, INC.
|
|
Peclinical Studies on a Polyunsaturated Fatty acid-Taxoid Conjugate for IND Fili
|
1R43CA132396-01
|
$99,109
|
$99,109
|
GUPTA, RAMESH
|
CHEM-MASTER INTERNATIONAL, INC
|
|
Delaware/Christiana Care CCOP
|
5U10CA045418-22
|
$1,042,698
|
$125,124
|
Grubbs, Stephen
|
CHRISTIANA CARE HEALTH SERVICES, INC.
|
|
City of Hope Southwest Oncology Group Clinical Trials
|
5U10CA046368-21
|
$315,196
|
$72,495
|
MORTIMER, JOANNE
|
CITY OF HOPE/BECKMAN RESEARCH INSTITUTE
|
|
Southwest Oncology Group
|
5U10CA004919-49
|
$192,303
|
$44,230
|
BUDD, G
|
CLEVELAND CLINIC LERNER COL/MED-CWRU
|
|
CCOP: Colorado Cancer Research Program
|
5U10CA067753-13
|
$873,364
|
$113,537
|
Pajon, Eduardo
|
COLORADO CANCER RESEARCH PROGRAM, INC.
|
|
Dual Compartmental Targeting of Cancer
|
5R01CA101988-05
|
$224,150
|
$112,075
|
GUSTAFSON, DANIEL
|
COLORADO STATE UNIVERSITY-FORT COLLINS
|
|
Total Synthesis and Biosynthesis of Bioactive Substances
|
5R01CA070375-12
|
$203,525
|
$101,763
|
WILLIAMS, ROBERT
|
COLORADO STATE UNIVERSITY-FORT COLLINS
|
|
Cancer Center Support Grant
|
2P30CA013696-35
|
$3,785,244
|
$37,852
|
DALLA-FAVERA, RICCARDO
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
Enhanced Intraarterial Delivery of Chemotherapeutic Drugs to the Brain
|
1R01CA127500-01A2
|
$363,748
|
$120,037
|
JOSHI, SHAILENDRA
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
Columbus Community Clinical Oncology Program
|
5U10CA035261-25
|
$874,908
|
$104,989
|
KUEBLER, J
|
COLUMBUS COMMUNITY CLINICAL ONCOLOGY PRG
|
|
ECOG Statistical Office
|
5U10CA023318-32
|
$2,367,125
|
$355,069
|
GRAY, ROBERT
|
DANA-FARBER CANCER INSTITUTE
|
|
Cancer and Leukemia Group B
|
5U10CA032291-27
|
$348,584
|
$156,863
|
WINER, ERIC
|
DANA-FARBER CANCER INSTITUTE
|
|
Dayton Clinical Oncology Program
|
5U10CA035090-26
|
$955,207
|
$114,625
|
Gross, Howard
|
DAYTON CLINICAL ONCOLOGY PROGRAM
|
|
Central Illinois Community Clinical Oncology Program
|
5U10CA045807-23
|
$1,053,633
|
$168,581
|
WADE, JAMES
|
DECATUR MEMORIAL HOSPITAL
|
|
Eastern Cooperative Oncology Group Chair's Office
|
5U10CA086802-10
|
$644,464
|
$96,670
|
COMIS, ROBERT
|
DREXEL UNIVERSITY
|
|
Cancer and Leukemia Group B
|
5U10CA047577-21
|
$166,705
|
$75,017
|
CRAWFORD, JEFFREY
|
DUKE UNIVERSITY
|
|
Cancer and Leukemia Group B Statistical Center
|
5U10CA033601-29
|
$5,067,063
|
$2,280,178
|
GEORGE, STEPHEN
|
DUKE UNIVERSITY
|
|
Nuclear EGFR Signaling Network in Human Cancer
|
5K01CA118423-03
|
$152,172
|
$30,434
|
Lo, Hui-Wen
|
DUKE UNIVERSITY
|
|
ACOSOG Competing Renewal
|
2U10CA076001-12
|
$3,011,166
|
$240,893
|
OTA, DAVID
|
DUKE UNIVERSITY
|
|
ACOSOG Competing Renewal
|
3U10CA076001-12S1
|
$342,900
|
$27,432
|
OTA, DAVID
|
DUKE UNIVERSITY
|
|
Duluth Community Clinical Oncology Program
|
5U10CA035269-25
|
$798,586
|
$71,873
|
Nikcevich, Daniel
|
DULUTH CLINIC, LTD.
|
|
Novel anti-melanoma agents and their mechanism of action
|
5R01CA095317-04
|
$257,865
|
$64,466
|
JOSHI, HARISH
|
EMORY UNIVERSITY
|
Total relevant funding to Taxol for this search: $63,184,616
|